AQUALYX™ is an injectable treatment of 12alfa-dihydroxy-5beta-24-oico cholanic acid sodium salts, which is a modified compound of cholanic acid. It is not a simple solution of deoxycholate. It is being marketed for ‘Aqualysis’ or ‘Aquaplasty’ treatment as a means of body contouring. This is a form of injection lipolysis, lipotherapy or intralipotherapy.
It was developed by Professor Pasquale Motolese, president of the Italian Society of Aesthetics and Medicine and first introduced in 2009. It is sometimes referred to as ‘Motolese`s Solution’.
AQUALYX is manufactured by the Italian firm Marllor and was first launched in the UK in 2013. It is distributed in the UK by Healthxchange Pharmacy.
AQUALYX was developed to treat localised pockets of fat underneath the surface of the skin.
It can be used to treat fat pockets on the back, chin, stomach, underneath the buttocks, hips, thighs and knees. It can also be used to treat pseudo-gynaecomastia, the development of fatty tissue around the nipple, resulting in a “breast”-like appearance in men, (due to weight gain rather than the growth of actual breast tissue as seen in genuine male gynaecomastia).
Clinical data shows that the application of AQUALYX is effective and safe, leading to an increasingly contoured appearance.